FDA Device recall Z-3108-2017
On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use
- FDA Device
- Class II
- terminated
- Published 2017-09-13
On 2017-09-13 the FDA classified a Class II recall of On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use by Cryolife, citing mix-up RGA (Return Goods Authorization) leading to 5 devices being redistributed and implanted 2 patients.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-3108-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-02-12 |
| Published | 2017-09-13 |
| Last updated | 2026-09-13 11:54 UTC |
| Company | Cryolife |
| Distribution | IL |
Product
On-X Prosthetic Heart Valve with Gelweave Valsalva Graft, single use. Indicated for the replacement of diseased, damaged, or malfunctioning native or prosthetic heart valves in the aortic position in cases that involve an ascending aortic aneurysm or other associated aortic disease.
Reason
Mix-up RGA (Return Goods Authorization) leading to 5 devices being redistributed and implanted 2 patients.
Identifiers
| code_info | Model No. ONXAAP; Serial No. 3260716, 3718302, 3190113, 3194122 and 3634902 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-3108-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.